33 Stocks Moving In Friday's Mid-Day Session

 

Gainers

  • Revlon, Inc. REV gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
  • Mereo BioPharma Group plc MREO surged 70% to $1.3580. AstraZeneca is rumored to be eyeing take over of Mereo BioPharma Group, according to a report in The Times.
  • Sesen Bio, Inc. SESN gained 30% to $0.7700.
  • bluebird bio, Inc. BLUE shares jumped 25.3% to $3.83. The FDA's Advisory Committee recently unanimously backed Bluebird bio’s gene therapy for a rare blood disorder.
  • Electric Last Mile Solutions, Inc. ELMS jumped 44% to $0.4061 after jumping 100% on Thursday.
  • Rhythm Pharmaceuticals, Inc. RYTM gained 21.2% to $4.7250. Rhythm Pharmaceuticals entered into a Revenue Interest Financing Agreement with HealthCare Royalty Partners for a total investment of $100 million. The U.S. Food and Drug Administration (FDA) has approved Rhythm Pharmaceuticals’ supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS).
  • PhaseBio Pharmaceuticals, Inc. PHAS gained 21.2% to $0.6280.
  • Scholar Rock Holding Corporation SRRK shares gained 20% to $5.83. Scholar Rock reported Phase 2 topaz trial extension data showing 'sizable and sustained motor function improvement at 24 months with apitegromab for non-ambulatory patients with types 2 and 3 spinal muscular atrophy.'
  • Seagen Inc. SGEN shares rose 18.5% to $174.00. Merck is eyeing purchase of biotech Seagen, while other unnamed suitors are also eyeing Seagen, the Wall Street Journal said.
  • Comera Life Sciences Holdings, Inc. CMRA gained 16.5% to $4.0777. Comera was granted U.S. patent titled 'Excipient compounds for protein processing.'
  • SoundHound AI, Inc. SOUN jumped 16.1% to $3.10.
  • Surrozen, Inc. SRZN gained 15.5% to $2.5650. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.
  • Sapiens International Corporation N.V. SPNS surged 15.1% to $24.09.
  • AeroClean Technologies, Inc. AERC jumped 14.3% to $20.25.
  • Allakos Inc. ALLK gained 14.2% to $2.9700.
  • Kinnate Biopharma Inc. KNTE rose 14.1% to $9.39.
  • Sight Sciences, Inc. SGHT jumped 12.9% to $8.46.
  • Calliditas Therapeutics AB CALT rose 8.5% to $17.26.
  • Athersys, Inc. ATHX rose 6.6% to $0.3411 after dropping more than 12% on Thursday.

 

 

Losers

  • Renovare Environmental, Inc RENO dipped 73.5% to $0.0450.
  • Addex Therapeutics Ltd ADXN shares fell 55.3% to $1.61 after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.
  • ToughBuilt Industries, Inc. TBLT fell 51.1% to $1.4899 after the company priced a $6 million offering.
  • Sidus Space, Inc. SIDU fell 21.7% to $5.97.
  • Advent Technologies Holdings, Inc. ADN dipped 20% to $3.1601. Advent Technologies recently announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
  • Neptune Wellness Solutions Inc. NEPT fell 19.5% to $2.19. Neptune Wellness appointed Raymond Silcock as Chief Financial Officer.
  • Acorda Therapeutics, Inc. ACOR fell 19.1% to $0.5001. Acorda Therapeutics shares jumped around 55% on Thursday after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
  • GlucoTrack, Inc. GCTK declined 15.3% to $2.00.
  • Hillstream BioPharma, Inc. HILS dropped 14.4% to $0.78.
  • Alvotech Ordinary Shares ALVO fell 13.4% to $9.78.
  • Calumet Specialty Products Partners, L.P. CLMT declined 12.2% to $10.13.
  • Heart Test Laboratories, Inc. HSCS dropped 12% to $2.13. Heart Test Laboratories announced pricing of its IPO of 1.5 million units at a price of $4.25 per unit.
  • Dream Finders Homes, Inc. DFH dipped 10.3% to $10.60. B of A Securities downgraded Dream Finders Homes from Neutral to Underperform and lowered the price target from $18 to $10.5.
  • Vivakor, Inc. VIVK fell 8.8% to $2.27. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.

 

Posted In: Mid-Day MoversTop GainersNewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading Ideas

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.